| 1,4-Butanediol | Dangerous | Combined CNS depression; risk of respiratory failure |
| 2M2B | Dangerous | Combined CNS depression; risk of respiratory failure |
| Acetylfentanyl | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Alcohol | Dangerous | Combined CNS depression; risk of respiratory failure |
| Alprazolam | Dangerous | Combined CNS depression; risk of respiratory failure |
| Atropa belladonna | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Baclofen | Dangerous | Combined CNS depression; risk of respiratory failure |
| Benzodiazepines | Dangerous | Combined CNS depression; risk of respiratory failure |
| Buprenorphine | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Cake | Dangerous | Combined CNS depression; risk of respiratory failure |
| Carisoprodol | Dangerous | Combined CNS depression; risk of respiratory failure |
| Clonazepam | Dangerous | Combined CNS depression; risk of respiratory failure |
| Clonazolam | Dangerous | Combined CNS depression; risk of respiratory failure |
| Clonidine | Dangerous | Combined CNS depression; risk of respiratory failure |
| Codeine | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Datura | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Deschloroetizolam | Dangerous | Combined CNS depression; risk of respiratory failure |
| Desomorphine | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Dextropropoxyphene | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Diazepam | Dangerous | Combined CNS depression; risk of respiratory failure |
| Diclazepam | Dangerous | Combined CNS depression; risk of respiratory failure |
| Dihydrocodeine | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Diphenhydramine | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Eszopiclone | Dangerous | Combined CNS depression; risk of respiratory failure |
| Ethylmorphine | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Etizolam | Dangerous | Combined CNS depression; risk of respiratory failure |
| F-Phenibut | Dangerous | Combined CNS depression; risk of respiratory failure |
| Fentanyl | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Flualprazolam | Dangerous | Combined CNS depression; risk of respiratory failure |
| Flubromazepam | Dangerous | Combined CNS depression; risk of respiratory failure |
| Flubromazolam | Dangerous | Combined CNS depression; risk of respiratory failure |
| Flunitrazepam | Dangerous | Combined CNS depression; risk of respiratory failure |
| Flunitrazolam | Dangerous | Combined CNS depression; risk of respiratory failure |
| Gabapentin | Dangerous | Combined CNS depression; risk of respiratory failure |
| Gaboxadol | Dangerous | Combined CNS depression; risk of respiratory failure |
| GBL | Dangerous | Combined CNS depression; risk of respiratory failure |
| GHB | Dangerous | Combined CNS depression; risk of respiratory failure |
| Grayanotoxin | Dangerous | Combined CNS depression; risk of respiratory failure |
| Harmala alkaloid | Dangerous | Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination |
| Heroin | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Hydrocodone | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Hydromorphone | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Kratom | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Lorazepam | Dangerous | Combined CNS depression; risk of respiratory failure |
| MAOI | Dangerous | Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination |
| Mephenaqualone | Dangerous | Combined CNS depression; risk of respiratory failure |
| Methadone | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Methaqualone | Dangerous | Combined CNS depression; risk of respiratory failure |
| Metizolam | Dangerous | Combined CNS depression; risk of respiratory failure |
| Midazolam | Dangerous | Combined CNS depression; risk of respiratory failure |
| Mirtazapine | Dangerous | Combined CNS depression; risk of respiratory failure |
| Morphine | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Myristicin | Dangerous | Compounding CNS depression with anticholinergic effects; risk of cardiac events and respiratory failure |
| Naloxone | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Nifoxipam | Dangerous | Combined CNS depression; risk of respiratory failure |
| O-Desmethyltramadol | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Oxycodone | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Oxymorphone | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Peganum harmala | Dangerous | Risk of hypertensive crisis and serotonin syndrome; potentially fatal combination |
| Pentobarbital | Dangerous | Combined CNS depression; risk of respiratory failure |
| Pethidine | Dangerous | Severe respiratory depression risk; leading cause of polydrug overdose |
| Phenobarbital | Dangerous | Combined CNS depression; risk of respiratory failure |
| SAMe | Dangerous | Combined CNS depression; risk of respiratory failure |
| 1,3-Butanediol | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 1B-LSD | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 1cP-AL-LAD | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 1cP-LSD | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 1cP-MiPLA | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 1P-ETH-LAD | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 1P-LSD | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 1V-LSD | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2-Aminoindane | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 2-FA | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 2-FEA | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 2-Fluorodeschloroketamine | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| 2-FMA | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 2,5-DMA | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 25B-NBOH | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 25B-NBOMe | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 25C-NBOH | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 25C-NBOMe | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 25D-NBOMe | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 25E-NBOH | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 25I-NBOH | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 25I-NBOMe | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 25N-NBOMe | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-B | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-B-FLY | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-C | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-D | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-E | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-H | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 2C-I | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-P | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-T | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-T-2 | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-T-21 | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 2C-T-7 | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 3-Cl-PCP | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| 3-FA | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 3-FEA | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 3-FMA | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 3-FPM | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 3-HO-PCE | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| 3-HO-PCP | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| 3-MeO-PCE | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| 3-MeO-PCMo | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| 3-MeO-PCP | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| 3-MMC | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 3,4-CTMP | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 3C-E | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 3C-P | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 4-AcO-DET | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 4-AcO-DiPT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 4-AcO-DMT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 4-AcO-MET | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 4-AcO-MiPT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 4-FA | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 4-FMA | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 4-HO-DET | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 4-HO-DiPT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 4-HO-DPT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 4-HO-EPT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 4-HO-MET | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 4-HO-MiPT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 4-HO-MPT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 4-MeO-PCP | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| 4-MMC | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 4F-EPH | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 4F-MPH | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 5-APB | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 5-MeO-DALT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 5-MeO-DiBF | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 5-MeO-DiPT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 5-MeO-DMT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 5-MeO-MiPT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 5F-AKB48 | Caution | Increased sedation and cognitive impairment |
| 5F-PB-22 | Caution | Increased sedation and cognitive impairment |
| 6-APB | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| 6-APDB | Caution | Increased cardiovascular strain and neurotoxicity risk |
| 8-Chlorotheophylline | Caution | Increased cardiovascular strain and neurotoxicity risk |
| A-PHP | Caution | Increased cardiovascular strain and neurotoxicity risk |
| A-PVP | Caution | Increased cardiovascular strain and neurotoxicity risk |
| AB-FUBINACA | Caution | Increased sedation and cognitive impairment |
| Adrafinil | Caution | Increased cardiovascular strain and neurotoxicity risk |
| AL-LAD | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| ALD-52 | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Allylescaline | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Amphetamine | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Anandamide | Caution | Increased sedation and cognitive impairment |
| APICA | Caution | Increased sedation and cognitive impairment |
| Armodafinil | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Ayahuasca | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Benzydamine | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Bromantane | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Bromo-DragonFLY | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Bufotenin | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Butylone | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Caffeine | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Cannabidiol | Caution | Increased sedation and cognitive impairment |
| Cannabis | Caution | Increased sedation and cognitive impairment |
| Cocaine | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Cyclazodone | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Deschloroketamine | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| Desoxypipradrol | Caution | Increased cardiovascular strain and neurotoxicity risk |
| DET | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Dextroamphetamine | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Dextromethorphan | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| Dichloropane | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Diphenidine | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| DiPT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| DMT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| DOB | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| DOC | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| DOI | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| DOM | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| DPT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Efavirenz | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Ephedrine | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Ephenidine | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| Ephylone | Caution | Increased cardiovascular strain and neurotoxicity risk |
| EPT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Escaline | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| ETH-CAT | Caution | Increased cardiovascular strain and neurotoxicity risk |
| ETH-LAD | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Ethylone | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Ethylphenidate | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Fenethylline | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Hexedrone | Caution | Increased cardiovascular strain and neurotoxicity risk |
| HXE | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| Ibogaine | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Inhalants | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| Isopropylphenidate | Caution | Increased cardiovascular strain and neurotoxicity risk |
| JWH-018 | Caution | Increased sedation and cognitive impairment |
| JWH-073 | Caution | Increased sedation and cognitive impairment |
| Ketamine | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| LAE-32 | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Lisdexamfetamine | Caution | Increased cardiovascular strain and neurotoxicity risk |
| LSA | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| LSD | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| LSM-775 | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| LSZ | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| MCPP | Caution | Increased cardiovascular strain and neurotoxicity risk |
| MDA | Caution | Increased cardiovascular strain and neurotoxicity risk |
| MDMA | Caution | Increased cardiovascular strain and neurotoxicity risk |
| MDPV | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Memantine | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| Mephedrone | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Mescaline | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| MET | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Methallylescaline | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Methamphetamine | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Methcathinone | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Methiopropamine | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Methoxetamine | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| Methoxphenidine | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| Methylnaphthidate | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Methylone | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Methylphenidate | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Mexedrone | Caution | Increased cardiovascular strain and neurotoxicity risk |
| MiPLA | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| MiPT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Modafinil | Caution | Increased cardiovascular strain and neurotoxicity risk |
| MPT | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| MXiPr | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| N-Ethylhexedrone | Caution | Increased cardiovascular strain and neurotoxicity risk |
| N-Methylbisfluoromodafinil | Caution | Increased cardiovascular strain and neurotoxicity risk |
| NEP | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Nitrous | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| NM-2-AI | Caution | Increased cardiovascular strain and neurotoxicity risk |
| O-PCE | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| Oxiracetam | Caution | Increased cardiovascular strain and neurotoxicity risk |
| PARGY-LAD | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| PCE | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| PCP | Caution | Both cause CNS depression; increased risk of vomiting, unconsciousness, and respiratory depression |
| Pentedrone | Caution | Increased cardiovascular strain and neurotoxicity risk |
| Phenylpiracetam | Caution | Increased cardiovascular strain and neurotoxicity risk |
| PRO-LAD | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Psilocybin Mushrooms | Caution | Increases anxiety, cardiovascular stress, and psychological intensity |
| Rhodiola Rosea | Caution | Increased cardiovascular strain and neurotoxicity risk |